查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1197528

医学成像模型市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

Medical Imaging Phantom Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 117 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内，医学影像模型市场预计将以 5.1% 的复合年增长率增长。

主要亮点

  • COVID-19 大流行对市场产生了影响。 大流行期间图像量的减少影响了市场增长的速度。 例如，根据 2021 年加拿大放射技术专家协会的一份报告，COVID-19 疫情对全国医学影像服务的等待时间产生了严重影响。 CT 扫描的等待时间为 50 至 82 天，MRI 扫描的平均等待时间为 89 天。 超过建议的 30 天等待时间 20 至 52 天。 由于 COVID-19，等待时间变得更长，影响了市场增长。 但是成像设备被用来观察疾病对患者的长期影响。 图像引导放射治疗的最新进展有望改善患者及其家人 (IGRT) 的生活质量。 例如，2022 年 9 月，Qure.ai 与鹿特丹大学医学中心合作推出了一个医学成像实验室。 最初计划为三年，我们计划使用胸部 CT、X 射线和脑部 CT 进行详细的医学影像诊断，以了解 COVID-19 的影响。 有了这样的合作伙伴关係，预计医学成像幻影市场将在预测期内增加。
  • 除了疾病负担加重等因素外，意识的提高和产品的进步预计也会推动市场增长。 需要成像来监测和了解大脑区域并了解它们如何对不同刺激做出反应的疾病（例如神经系统疾病）的增加预计将促进市场增长。 例如，根据世界卫生组织 (WHO) 2022 年 9 月的报告，全球约有 5500 万人患有痴呆症，每年报告的病例近 1000 万例。 此外，根据同一数据，阿尔茨海默型痴呆最为常见，约占所有痴呆患者的 60-70%。 同样，根据世界卫生组织 2022 年 2 月的更新，癫痫影响了全球约 5000 万人，使癫痫成为最常见的神经系统疾病之一，80% 的低度至中度癫痫患者生活在收入国家。 因此，神经系统疾病的高负担预计会增加市场增长，因为它需要医学影像为患者提供特定护理，并且研究市场有望增长。
  • 同样，补贴为在药物开发中使用幻影图像提供基础设施支持，这是市场增长的另一个驱动力。 例如，2022 年 3 月，Gold Standard Phantom 入选 2022 P4 精准医疗加速器计划。 对于这个项目，公司投资了一个专用于体内 MRI 人体组织和器官成像的体模。 通过传授无与伦比的专业知识、关键关係和新联繫，这个由伦敦大学学院和 Capital Enterprises 协调的为期六个月的计划将帮助精准医学中小企业成长并采用它创造一个新的和独特的环境。 因此，由于上述因素，如疾病负担增加，以及意识和产品进步的提高，预计医学成像幻影市场将在预测期内增长。 然而，该程序的高成本和缺乏训练有素的专业人员预计会阻碍市场增长。

医学影像幻影市场趋势

在医学影像模型市场，核医学影像模型有望占据主要市场份额

Nuclear Medicine Imaging Phantom是专门为医学影像领域的扫描成像设计的系统，用于评估、分析和校准PET/CT等各种影像仪器的性能。 . 癌症患者增加等因素加上主要参与者的举措预计将推动市场增长。 例如，根据 Cancer Facts & Figures 2022 的数据，2022 年美国将发生 190 万新癌症病例和 609,360 例癌症死亡。 在全球范围内，由于癌症流行，研究 PET 成像的使用正在增加。 许多学术研究正在研究核医学成像在癌症中的应用。 例如，在 2021 年 4 月发表于国家医学图书馆的一项研究中，FDG PET/CT 成像检测了新诊断、未经治疗的口腔鳞状细胞癌 (SCC) 患者的颈部淋巴结转移，发现其具有很高的阴性预测价值 因此，研究调查的增加有望通过提供对核医学成像应用的洞察力来增加其在治疗各种疾病中的采用，这有望促进市场增长。 因此，未来的市场增长将会增加。

此外，主要市场参与者的收购等举措也有助于市场增长，因为收购有助于扩大产品领域和/或地区的主要参与者。 例如，2021 年 9 月，Million Technologies, Inc. 收购了 Computerized Image Reference Systems, Inc.，这是一家为医疗行业提供医学成像和放射治疗模型的供应商。 预计这些努力将增加产品在各个地区的可用性并促进市场的增长。 因此，上述因素有望推动医学影像模型市场的发展。

预计北美将占据很大的市场份额，预计在预测期内也会如此

由于该地区资金和产品引进的增加，预计北美将占据医学成像模型市场的很大份额。

该地区不断增加的资金预计将在预测期内推动医学成像的采用并促进市场增长。 例如，2021 年 7 月，加拿大联邦政府和魁北克省将与联邦基础设施和社区部长以及卫生部长和社会服务分别投资于 209 个基础设施项目，其中一部分为 1.883 亿美元。 这笔资金使医院能够获得先进的医疗技术。 因此，预测期内新医院的建设预计将增加医学成像的采用，增加该地区对医学成像模型的需求。

此外，医疗机构的产品安装是市场增长的另一个驱动力，因为它促进了该技术在该地区的广泛采用。 例如，2022 年 11 月，Perimeter Medical Imaging AI Inc. 在德克萨斯州北部的一家医院安装了 Perimeter S 系列 OCT 系统。 Perime 是一家医疗技术公司，通过超高分辨率、实时、先进的成像工具推动癌症手术的转型，以满足未满足的医疗需求。 因此，预计此类安装将在预测期内推动市场增长。 因此，上述因素，如增加资金、产品引入等，有望促进医学影像模型市场的增长。

医学影像模型市场竞争对手分析

医学成像模型市场竞争适中，由几家大型企业组成，目前的市场垄断者包括 Carville、Computerized Imaging Reference Systems, Inc、Pure Imaging Phantoms 和 Biodex。Medical System, Inc、Leeds Test Object Ltd、 Bartec Technologies Ltd、Gold Standard Phantoms、Kyoto Kagaku、Modus Medical Device Inc、PTW Freiburg GmbH。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第1章介绍

  • 研究假设和市场定义
  • 调查范围

第2章研究方法论

第 3 章执行摘要

第4章市场动态

  • 市场概览
  • 市场驱动力
    • 慢性病负担加重
    • 产品演变
    • 提高对诊断成像的认识
  • 市场製约因素
    • 手术费用上涨
    • 缺乏训练有素的专业人员
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：百万美元）

  • 按产品类型
    • X射线体模
    • 超声波幻影
    • 核磁共振模型
    • 核医学检查体模
    • 其他产品类型
  • 按材料
    • 刺激器
    • 假器官
  • 最终用户
    • 医院
    • 诊断中心
    • 其他最终用户
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东和非洲
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章竞争格局

  • 公司简介
    • Bartec Technologies Ltd
    • Biodex Medical System Inc.
    • Carville
    • Computerized Imaging Reference Systems Inc.
    • Gold Standard Phantoms
    • Kyoto Kagaku Co. Ltd
    • Leeds Test Object Ltd
    • Modus Medical Device Inc.
    • PTW Freiburg GmbH
    • Pure Imaging Phantoms
    • QUART GmbH
    • True Phantom Solutions

第7章 市场机会与今后动向

简介目录
Product Code: 68529

The Medical Imaging Phantom Market is expected to register a CAGR of 5.1% during the forecast period.

Key Highlights

  • The market was affected by the COVID-19 pandemic. The decrease in imaging volumes during the pandemic affected the growth pace of the market. For instance, the COVID-19 epidemic had a severe impact on wait times for medical imaging operations across the country, according to a report from the Canadian Association of Radiologists in 2021. For CT scans, the wait time ranged from 50 to 82 days, and for MRI imaging, it was 89 days on average. That exceeded the advised 30-day wait time by 20 to 52 days. Waitlists were even longer as a result of COVID-19, affecting the market growth. However, imaging instruments were used to identify the long-term effect of diseases on patients. Recent advancements in image-guided radiation therapy are expected to improve the quality of life for patients and their families (IGRT). For instance, in September 2022, Qure.ai partnered with the University Medical Center Rotterdam to launch a laboratory for medical imaging. The initial program is estimated to run for 3 years to conduct detailed medical imaging to understand the effects of COVID-19 with the help of Chest CTs, X-rays, and brain CTs. Thus, with such partnerships, the medical imaging phantom market is expected to increase during the forecast period.
  • Factors such as the increasing burden of diseases, coupled with growing awareness and advancement in products are expected to increase the market growth. Increasing diseases such as neurological diseases which require imaging to monitor and understand the areas of the brain to check how it reacts to different stimuli are expected to increase the market growth. For instance, as per the September 2022 report of the World Health Organization (WHO), about 55 million people around the world were living with dementia, and nearly 10 million cases are reported every year. Also, as per the same source, Alzheimer's is the most common form of dementia and constitutes about 60-70% of the total cases of dementia. Similarly, according to the February 2022 update of the WHO, about 50 million people with epilepsy are living around the world, making it one of the most prevalent neurological diseases, with 80% of the population with epilepsy residing in low- and middle-income countries. Hence, the high burden of neurological disorders is expected to increase the market growth as they require medical imaging to provide specific care to patients, and the studied market is expected to grow.
  • Similarly, grants are another factor in market growth as they provide infrastructural support for the utilization of phantom imaging in drug development. For instance, in March 2022, Gold Standard Phantoms was selected for the 2022 P4 Precision Medicine Accelerator Programme. The company invested in specialized phantoms for MRI human tissue and organ imaging in living subjects under this project. By granting access to unmatched expertise, significant relationships, and new connections, this six-month program, coordinated by University College London and Capital Enterprise, establishes a novel and distinctive environment to support the growth and adoption of precision medicine SMEs. Thus, such grants utilize imaging phantoms in drug developments which increases the market growth during the forecast period. Thus, with the abovementioned factors such as the increasing burden of diseases, coupled with growing awareness and advancement in products, the medical imaging phantom market is expected to grow over the forecast period. However, the high cost of procedures and the lack of trained professionals are expected to hinder market growth.

Medical Imaging Phantom Market Trends

Nuclear Imaging Phantoms Segment is Expected to Hold a Major Market Share in the Medical Imaging Phantom Market

A nuclear imaging phantom is a specially designed system that scans or is imaged in the field of medical imaging to evaluate, analyze, and tune the performance of various imaging devices like PET/CT, etc. Factors such as increasing cancer cases coupled with initiatives by key players are expected to increase the market growth. For instance, according to data from Cancer Facts & Figures 2022, 1.9 million new cancer cases will be discovered, and there will be 609,360 cancer fatalities in the US in 2022. Globally, the use of PET imaging for research has increased as a result of the prevalence of cancer. Numerous academic research has examined the application of nuclear imaging in cancer. For instance, a study that was published in the National Library of Medicine in April 2021 found that FDG PET/CT imaging had a high negative predictive value in detecting cervical lymph node metastasis in patients with newly diagnosed, treatment-naive squamous cell carcinoma (SCC) of the oral cavity. Thus, increasing research studies are expected to increase market growth by providing insight into the applications of nuclear imaging, which is expected to increase the adoption for the treatment of various diseases. Thus, increasing the market growth in the future.

Furthermore, initiatives such as acquisitions by key market players are another factor in market growth as acquisitions help the expansion of key players either in product segments or geography, or both. For instance, in September 2021, Mirion Technologies Inc. acquired Computerized Imaging Reference Systems Inc., a provider of medical imaging and radiation therapy phantoms serving the medical industry. Such initiatives are expected to increase the availability of products in various regions and thus increase the market growth. Thus, the abovementioned factors are expected to increase the medical imaging phantom market growth.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to have a significant share in the medical imaging phantom market due to the increased funding and product installation in the region.

The increased funding in the region is expected to increase the adoption of medical imaging, which is expected to increase market growth during the forecast period. For instance, in July 2021, to improve Quebec's health and social services infrastructure, including hospitals and other care facilities, the federal government of Canada and the province of Quebec partnered to invest in 209 infrastructure projects in part by USD 188.3 million each from the Federal Minister of Infrastructure and Communities and the Minister of Health and Social Services. The funds provided hospitals with access to sophisticated medical technology. Thus, the building of new hospitals during the forecast period is expected to increase the adoption of medical imaging, which is expected to increase the demand for medical imaging phantom in the region.

In addition, product installation in healthcare facilities is another factor in market growth as it increases the wider adoption of the technology in the region. For instance, in November 2022, Perimeter Medical Imaging AI Inc. installed the Perimeter S-Series OCT system in a hospital in North Texas. Perimeter is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs. Thus, such installations are expected to increase market growth over the forecast period. Thus, the abovementioned factors such as increasing funding, and product installations are expected to increase the medical imaging phantom market growth.

Medical Imaging Phantom Market Competitor Analysis

The medical imaging phantom market is moderately competitive and consists of several major players, and some of the companies which are currently dominating the market are Carville, Computerized Imaging Reference Systems, Inc., Pure Imaging Phantoms, Biodex Medical System, Inc., Leeds Test Object Ltd., Bartec Technologies Ltd., Gold Standard Phantoms, Kyoto Kagaku Co., Ltd, Modus Medical Device Inc., and PTW Freiburg GmbH among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of Chronic Diseases
    • 4.2.2 Advancement in Products
    • 4.2.3 Growing Awareness about Diagnostic Imaging
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Procedures
    • 4.3.2 Lack of Trained Professionals
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product Type
    • 5.1.1 X Ray Phantoms
    • 5.1.2 Ultrasound Phantoms
    • 5.1.3 MRI Phantoms
    • 5.1.4 Nuclear Imaging Phantoms
    • 5.1.5 Other Product Types
  • 5.2 By Material
    • 5.2.1 Stimulating Devices
    • 5.2.2 False Organ
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Diagnostic Centers
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Bartec Technologies Ltd
    • 6.1.2 Biodex Medical System Inc.
    • 6.1.3 Carville
    • 6.1.4 Computerized Imaging Reference Systems Inc.
    • 6.1.5 Gold Standard Phantoms
    • 6.1.6 Kyoto Kagaku Co. Ltd
    • 6.1.7 Leeds Test Object Ltd
    • 6.1.8 Modus Medical Device Inc.
    • 6.1.9 PTW Freiburg GmbH
    • 6.1.10 Pure Imaging Phantoms
    • 6.1.11 QUART GmbH
    • 6.1.12 True Phantom Solutions

7 MARKET OPPORTUNITIES AND FUTURE TRENDS